Overview

Dose-escalation Study of a Contrast Agent for Delineation of Urological Anatomy in Minimally Invasive Surgery

Status:
Completed
Trial end date:
2018-11-19
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to study the safety and efficacy of an investigational imaging agent for delineation/visualization of urologic anatomy in the setting of minimally invasive surgery.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Li-Cor, Inc.